Updated on 2025/05/26

Information

 

写真a

 
Hu Qingjiang
 
Organization
Beppu Hospital Department of Surgery Assistant Professor
Title
Assistant Professor
Tel
0926425466
Profile
平成23年九州大学医学部を卒業し、2年間の初期臨床研修を済生会福岡総合病院にて行った。初期臨床研修を終了した後に、平成25年に九州大学第二外科に入局した。1年間済生会福岡総合病院で外科レジデントを経て、大学院に進学した。大学院では主に胃癌の新規癌遺伝子の同定を中心に研究を行った。平成30年に医学博士号を取得した。その後臨床に戻り、消化器外科医として研鑽を積み、外科専門、消化器外科専門医、癌治療認定医を取得した。手術はもちろん、化学療法、免疫療法を中心に、患者さんにとって最適な医療を提供するように心掛けている。 【学会活動】 日本外科学会・専門医 日本消化器外科学会・専門医 日本消化器外科学会・消化器がん外科治療認定医 日本がん治療認定医機構・がん治療認定医 臨床研修指導医 日本癌治療学会 日本癌学会 日本臨床腫瘍学会 米国癌学会(AACR)

Degree

  • M.D., Ph.D.

Research Interests・Research Keywords

  • Research theme： Utility of ctDNA in esophageal cancer.

    Keyword： ctDNA, esophageal cancer

    Research period： 2022.5

  • Research theme： Cytolytic activity score as a biomarker for anti-tumor immunity and clinical outcome in patients with gastric cancer

    Keyword： gastric cancer, immune

    Research period： 2020.2 - 2021.2

Papers

  • Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer Invited Reviewed International journal

    Qingjiang Hu, Takaaki Masuda, Kensuke Koike, Kuniaki Sato, Taro Tobo, Shotaro Kuramitsu, Akihiro Kitagawa, Atsushi Fujii, Miwa Noda, Yusuke Tsuruda, Hajime Otsu, Yosuke Kuroda, Shuhei Ito, Eiji Oki, Koshi Mimori

    SCIENTIFIC REPORTS   11 ( 1 )   2021.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1038/s41598-021-98485-9

  • Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer Invited Reviewed International journal

    Qingjiang Hu 1 , Kentaro Nonaka 1 , Hiroaki Wakiyama 2 , Yu Miyashita 1 , Yoshiaki Fujimoto 1 , Tomoko Jogo 1 , Kentaro Hokonohara 1 , Ryota Nakanishi 1 , Yuichi Hisamatsu 1 , Koji Ando 1 , Yasue Kimura 1 , Takaaki Masuda 2 , Eiji Oki 1 , Koshi Mimori 2 , Yoshinao Oda 3 , Masaki Mori 1

    CANCER MEDICINE   2021.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1002/cam4.3828

  • Influence of Robotic Rectal Resection Versus Laparoscopic Rectal Resection on Postoperative Ileus: A Single-center Experience Invited Reviewed International journal

    Qingjiang Hu, Eiji Oki, Yoshiaki Fujimoto, Tomoko Jogo, Kentaro Hokonohara, Ryota Nakanishi, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Masaki Mori

    Surg Laparosc Endosc Percutan Tech.   2022.4

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Aim: This study was performed to clarify the relationship between robotic rectal resection and postoperative ileus (POI) by comparing robotic surgery with laparoscopic surgery.

    Materials and methods: We retrospectively reviewed 238 patients who underwent robotic (n=41) or laparoscopic (n=197) rectal resection for rectal cancer in our institution from January 2013 to June 2020. First, we compared the background factors and short-term surgical outcomes between robotic and laparoscopic surgery. Next, we investigated the postoperative complications of robotic and laparoscopic rectal resection. Finally, we identified the risk factors for POI following rectal cancer resection.

    Results: The percentages of patients with an Rb tumor location, treatment by abdominoperitoneal resection/intersphincteric resection/low anterior resection, a temporary diverting ileostomy, and a long operation time were significantly higher in robotic than laparoscopic surgery (P<0.0001,P=0.0002,P=0.0078, andP=0.0001, respectively). There was no significant difference in any individual postoperative complication between robotic and laparoscopic surgery. Risk factors for POI were male sex (P=0.0078), neoadjuvant chemoradiotherapy (P=0.0007), an Rb tumor location (P=0.0005), treatment by abdominoperitoneal resection/intersphincteric resection/low anterior resection (P=0.0044), a temporary diverting ileostomy (P<0.0001), and operation time of ≥240 minutes (P=0.0024). Notably, robotic surgery was not a risk factor for POI following rectal resection relative to laparoscopic surgery.

    Conclusion: Although patients who underwent robotic surgery had more risk factors for POI, the risk of POI was similar between robotic and laparoscopic rectal resection.

  • Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT Invited Reviewed International journal

    Qingjiang Hu 1 2 , Takaaki Masuda 1 , Shotaro Kuramitsu 1 , Taro Tobo 3 , Kuniaki Sato 1 , Shinya Kidogami 1 , Sho Nambara 1 , Masami Ueda 1 , Yusuke Tsuruda 1 , Yosuke Kuroda 1 , Shuhei Ito 1 , Eiji Oki 2 , Masaki Mori 2 , Koshi Mimori 1

    PLOS ONE   15 ( 10 )   2020.10

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1371/journal.pone.0241140

  • ASO Author Reflections: ARL4C and Peritoneal Dissemination in Gastric Cancer Invited Reviewed International journal

    Qingjiang Hu 1 2 , Koshi Mimori 3

    ANNALS OF SURGICAL ONCOLOGY   26   S547 - S547   2019.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1245/s10434-018-7056-7

  • Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer Invited Reviewed International journal

    Qingjiang Hu 1 2 , Takaaki Masuda 1 , Kuniaki Sato 1 , Taro Tobo 3 , Sho Nambara 1 , Shinya Kidogami 1 , Naoki Hayashi 1 , Yosuke Kuroda 1 , Shuhei Ito 1 , Hidetoshi Eguchi 1 , Hiroshi Saeki 2 , Eiji Oki 2 , Yoshihiko Maehara 2 , Koshi Mimori 4

    ANNALS OF SURGICAL ONCOLOGY   25 ( 3 )   745 - 753   2018.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1245/s10434-017-6292-6

  • Splenectomy Followed by Hepatectomy for Hepatocellular Carcinoma with Hypersplenism and Portal Hypertension Caused by Macroglobulinemia Invited Reviewed International journal

    Qingjiang Hu 1 , Kazuki Takeishi 2 , Yo-Ichi Yamashita 1 , Tetsuo Ikeda 1 , Huanlin Wang 1 , Shinji Itoh 1 , Norifumi Harimoto 1 , Toru Ikegami 1 , Tomoharu Yoshizumi 1 , Hirofumi Kawanaka 1 , Ken Shirabe 1 , Yoshihiko Maehara 1

    ANTICANCER RESEARCH   35 ( 7 )   4077 - 4081   2015.7

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

▼display all

Research Projects

  • 空間的トランスクリプトーム解析を用いた大腸癌ドライバー遺伝子と局所免疫との関連の解明

    2021 - 2022

    2021年度バイエル薬品アカデミックサポート

    　 More details

    Authorship：Principal investigator  Grant type：Contract research

  • in silico解析で同定した胃癌新規癌遺伝子の生物学的意義と臨床的意義

    Grant number：19K16718  2019 - 2021

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Early-Career Scientists

    　 More details

    Authorship：Principal investigator  Grant type：Scientific research funding

  • 進行再発胃癌におけるcytolytic activity scoreとPD-1阻害の治療効果との関連

    2019 - 2021

    ヒロセ財団研究助成金

    　 More details

    Authorship：Principal investigator  Grant type：Contract research

Educational Activities

  • 消化管外科のスタッフとして、主に大学院生の研究と論文指導に従事している。胃癌及び食道癌における新規遺伝子の同定、ゲノム検査を用いた抗がん剤耐性機序の解明、ctDNAを用いたリキッドバイオプシーの応用、免疫チェックポイント分子SIRPAの役割、局所腫瘍免疫及び浸潤細胞の解析が主なテーマで新規論文作成中である。大学院生に対して、学位を取るための研究ではなく、サイエンスを推進するとともに、患者さんにメリットとなるように教育を行っている。

Outline of Social Contribution and International Cooperation activities

  • 【学会発表】
    １） 第120回日本外科学会学術集会
    Potential association of LOXL1 with peritoneal dissemination in gastric cancer via promotion of EMT
    サージカルフォーラム（口演）
    2020年8月13日　パシフィコ横浜
    Qingjiang Hu, Takaaki Masuda, Yasuo Tsuda, Yoko Zaitsu, Yuichi Hisamatsu, Yuichiro Nakashima, Koji Ando, Yasue Kimura, Eiji Oki, Koshi Mimori, Masaki Mori

    ２） 第75回消化器外科学会総会
    Clinical experience of nivolumab for advanced or recurrent gastric cancer in our hospital
    ポスター
    2020年12月15日〜17日　和歌山
    Qingjiang Hu, Hirofumi Hasuda, Yoshiaki Fujimoto, Tomoko Jogo, Kentaro Hokonohara, Ryota Nakanishi, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Eiji Oki, Masaki Mori

    ３）第92回胃癌学会総会
    Clinical experience of nivolumab for advanced gastric cancer in our hospital
    ポスター
    2020年7月1日〜31日　パシフィコ横浜
    Qingjiang Hu, Yasuo Tsuda, Yoko Zaitsu, Yuichi Hisamatsu, Yuichiro Nakashima, Koji Ando, Yasue Kimura, Eiji Oki, Masaki Mori

    ４）第53回制癌剤適応研究会
    切除不能進行再発胃癌へのニボルマブの使用経験
    要望演題（口演）
    2020年2月21日　琵琶湖ホテル
    胡　慶江、津田康雄、財津瑛子、久松雄一、中島雄一郎、安藤幸滋、木村　和恵、沖　英次、森　正樹

    ５）第33回日本バイオセラピィ学会学術集会総会　
    胃癌局所免疫を反映する細胞融解活性スコア（CYT）の臨床的意義.
    要望演題（口演）
    2020年11月19日〜20日　福岡
    胡　慶江、藤本禎明、城後友望子、鉾之原健太郎、中西良太、久松雄一、安藤幸滋、木村和恵、沖　英次、三森功士、森　正樹

    ６）2020 AACR Virtual Meeting II
    LOXL1 is a novel responsible gene for peritoneal dissemination potentially via promoting EMT and motility in gastric cancer
    Poster
    June 22 through June 24, 2020
    Qingjiang Hu, Takaaki Masuda, Yoko Zaitsu, Yasuo Tsuda, Yuichi Hisamatsu, Yuichiro Nakashima, Koji Ando, Yasue Kimura, Eiji Oki, Masaki Mori, Koshi Mimori


    【2021年度】
    1) 第121回日本外科学会定期学術集会
    一般演題（直腸）
    ロボット支援下手術と腹腔鏡下手術における術後腸閉塞頻度の検討
    Comparison of the frequency of postoperative ileus between robot-assisted and laparoscopic surgery
    胡　慶江、沖　英次、藤本　禎明、城後　友望子、鉾之原　健太郎、中西　良太、久松　雄一、安藤　幸滋、木村　和恵、森　正樹

    2) 第34回内視鏡外科学会
    一般演題
    GISTに対する腹腔鏡下胃局所切除術におけるICGクリップの臨床応用
    Clinical usefulness of ICG clip in laparoscopic partial gastrectomy for GIST.
    Qingjiang Hu, Yosuke Minoda, Yu Nakaji, Ryota Nakanishi, Tomonori Nakanoko,
    Koji Ando, Mitsuhiko Ota, Yasue Kimura, Eiji Oki

    3) 第94回日本胃癌学会
    シンポジウム
    Real world data of genomic profiling test in patients with gastric cancer at our institution
    Qingjiang Hu1, Mamoru Ito2, Yu Nakaji1, Ryota Nakanishi1, Tomonori Nakanoko1, Koji Ando1, Mitsuhiko Ota1, Yasue Kimura1, Eiji Oki1
    1 Department of Surgery and Science, Kyushu University Hospital
    2 Department of Medicine and Biosystemic science, Kyushu University Hospital
    ワークショップ
    Clinical impact of skeletal muscle loss in patients with recurrent or advanced gastric cancer treated with nivolumab
    Qingjiang Hu1, Kensuke Kudo2, Takafumi Yukaya3, Hirofumi Hasuda1, Yu Nakaji1,
    Ryota Nakanishi1, Tomonori Nakanoko1, Koji Ando1, Mitsuhiko Ota1, Yasue Kimura1, Eiji Oki1
    1 Department of Surgery and Science, Kyushu University Hospital
    2 Department of Gastrointestinal surgery, Kyushu Medical Center
    3 Department of Surgery, ASO Iizuka Hospital

    4) ASCO-GI2022
    Poster
    Geriatric-8 (G8) screening tool predicts the efficacy of S-1 plus ramucirumab in elderly patients with advanced/recurrent gastric cancer: An ad-hoc analysis of the KSCC1701 trial.
    Qingjiang Hu1, Koichi Suyama2, Kazuma Kobayashi3, Hiroo Katsuya4, Naoki Izawa5, Yoshikazu Uenosono6, Tetsuya Kusumoto7, Hajime Otsu8, Hiroyuki Orita9, Hirofumi Kawanaka10, Kazunori Shibao11, Satoshi Koga12, Mototsugu Shimokawa13, Akitaka Makiyama14, Hiroshi Saeki15, Eiji Oki1, Hideo Baba16, Masaki Mori17
    1Kyushu University; 2Toranomon Hospital; 3Nagasaki University; 4Saga University; 5St. Marianna University; 6Imamura General Hospital; 7National Kyushu Medical Center; 8Kyushu University Beppu Hospital; 9Nakatsu Municipal Hospital; 10National Hospital Organization Beppu Medical Center; 11University of Occupational and Environmental Health; 12Iizuka Hospital; 13Yamaguchi University; 14Gifu University Hospital; 15Gunma University; 16Kumamoto University; 17Tokai University; Kyusyu Study of Clinical Cancer (KSCC), Japan.

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Surgical Clinical Medicine / Gastrointestinal Surgery

Clinician qualification

  • Specialist

    Japan Surgical Society（JSS）

  • Specialist

    The Japanese Society of Gastroenterological Surgery

Year of medical license acquisition

  • 2011

Notable Clinical Activities

  • 消化管一般、特に胃癌、大腸癌の手術と化学療法を中心に診療を行っております。